Product Images Toujeo Max
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 52 images provide visual information about the product associated with Toujeo Max NDC 0024-5871 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - toujeo 01
Figure 1 - toujeo 02
Figure - toujeo 03
This text indicates specific body parts that could be targeted during a workout or used to monitor changes in physical fitness. Upper arms, stomach, and thighs are commonly focused on during exercise as they are areas that people may want to tone or strengthen.*
Figure - toujeo 04
This appears to be a diagram or schematic of an insulin injection device. It features a dose window, dose pointer, dose selector, rubber seal, insulin scale, insulin name, and injection button. The text notes that the plunger is not visible until after a few doses have been injected.*
Figure - toujeo 05
Figure - toujeo 06
Figure - toujeo 07
Figure - toujeo 08
Figure - toujeo 09
Figure - toujeo 10
Figure - toujeo 11
Figure - toujeo 12
Figure - toujeo 13
Figure - toujeo 14
Figure - toujeo 15
Figure - toujeo 16
Figure - toujeo 17
Figure - toujeo 18
Figure - toujeo 19
Figure - toujeo 20
Figure - toujeo 21
Figure - toujeo 22
Figure - toujeo 23
Figure - toujeo 24
Figure - toujeo 25
figure - toujeo 26
Figure - toujeo 27
This appears to be a list of body parts - upper arms, stomach, and thighs. It is not clear what context this list is related to.*
Figure - toujeo 28
This text describes the components of a typical insulin pen used for injecting insulin. It mentions the cartridge holder, the dose window, dose pointer, dose selector, injection button, plunger, insulinscale, insulin name, pen cap and rubber seal. It also notes that the plunger will not be visible until a few doses are administered.*
Figure - toujeo 29
Figure - toujeo 30
Figure - toujeo 31
Figure - toujeo 32
Figure - toujeo 33
Figure - toujeo 34
Figure - toujeo 35
Figure - toujeo 36
Figure - toujeo 37
Figure - toujeo 38
Figure - toujeo 39
Figure - toujeo 40
Figure - toujeo 41
Figure - toujeo 42
Figure - toujeo 43
Figure - toujeo 44
Figure - toujeo 45
Figure - toujeo 46
Figure - toujeo 47
Figure - toujeo 48
Figure - toujeo 49
Figure - toujeo 50
PRINCIPAL DISPLAY PANEL - 1.5 mL Pen Carton - toujeo 51
This is the description for an insulin medication called Toujeo Solostar. It is indicated for subcutaneous injection only and should be used within 56 days of opening it. It comes in a disposable insulin delivery device and should not be removed with a syringe. It is not meant to be mixed with other insulins and should only be used if the solution is clear and colorless with no visible particles. This package includes three prefilled pens of 450 units each. The instructions warn to only use new needles and to store the unopened and opened device properly.*
PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton - toujeo 52
This is a description of a insulin drug called "Toujeo Max Solostar". It is for single patient use only and is intended for subcutaneous injection only. It comes in a disposable insulin delivery device and should not be removed with a syringe. It is recommended to use a new needle every time. Mixing with other insulins is not allowed. It should only be used if the solution is clear and colorless with no particles visible, along with a security sticker. After opening, the solution should be used within 56 days. The text also contains instructions for storage and dosage, as well as information about needles that should be used.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.